[New, in Austria registered specialty drugs. Neupogen (G-CSF)].
D000818:Animals; D001317:Austria; D004305:Dose-Response Relationship, Drug; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D009503:Neutropenia / Q000628:therapy; D009894:Opportunistic Infections / Q000628:therapy; D011994:Recombinant Proteins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor
Neue, in Osterreich registrierte Spezialitäten. Neupogen (G-CSF).